Forte Biosciences (FBRX) Change in Cash (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Change in Cash data on file, last reported at -$18.7 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 179.34% year-over-year to -$18.7 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 19.76% decrease from a year earlier, with the FY2025 full-year figure at $54.7 million, up 467.67% from the prior year.
• Change in Cash for Q1 2026 stood at -$18.7 million, down from -$16.5 million in the prior quarter.
• Over the last five years, Change in Cash for FBRX reached as high as $60.3 million in Q2 2025 and fell as low as -$18.7 million in Q1 2026.
• Historically, Change in Cash has averaged $951705.9 across 5 years, with a median of -$5.2 million in 2023.
• Across the five-year window, Change in Cash sank 939.95% in 2023 and soared 1113.93% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$2.9 million in 2022, then slumped by 207.33% to -$9.1 million in 2023, then soared by 164.91% to $5.9 million in 2024, then tumbled by 379.83% to -$16.5 million in 2025, then slipped by 13.84% to -$18.7 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$18.7 million in Q1 2026, -$16.5 million in Q4 2025, and -$12.7 million in Q3 2025.